Shanghai Authorities Discipline Scientists Over Fatal Gene-Editing Trial - Bloomberg
Two lead researchers at Shanghai Jiao Tong University School of Medicine were dismissed after a child died during a gene-editing study they ran. They are also barred from government science and technology projects for five years, according to China Central Television.
- The two researchers leading the study were fired, and the university's response followed a child's death in the trial.
- The pair were barred for five years from government science and technology projects, a sanction that goes beyond losing their jobs.
- The report came from state media CCTV on Friday, November 13, 2026.
China has fired two lead researchers from a gene-editing study at Shanghai Jiao Tong University School of Medicine after a child died during the trial. State broadcaster China Central Television reported the dismissals on Friday, and said both researchers have also been barred for five years from government science and technology projects. That is a serious penalty, and it signals that Beijing is treating the death as a governance failure rather than an unavoidable clinical risk.
The article is short, and the headline and takeaway carry most of the reporting. What it does not give you, at least in this version, is much about the trial itself: what the gene-editing intervention was meant to treat, how the child died, or whether regulators found misconduct in consent, monitoring, or reporting. Those details matter a lot for judging whether this is a story about one bad study or about weak oversight of experimental medicine in China more broadly. If you want the full picture, the CCTV report it links to is the primary source to check next.
Still, the core facts are worth saving: a fatal adverse event in a gene-editing trial, personnel removed, and a multiyear ban from state research funding. For anyone following gene-editing ethics, this kind of case tends to shape how regulators handle trial safety reporting and researcher accountability in the months that follow.